Bausch Health Companies | VRX - Operating Profit

Stock Price
7.31
Daily Change
-0.19 -2.53%
Monthly
0.83%
Yearly
6.56%
Q2 Forecast
7.29

Bausch Health Companies reported $719M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Amgen USD 3.96B 464M Dec/2025
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -35.79M 19.88M Dec/2025
Bausch Health Companies USD 719M 2M Dec/2025
Biogen USD 659.6M 192.2M Sep/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Drreddys Laboratories INR 14.33B 2.51B Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Pacira USD 3.19M 9.96M Dec/2025
Perrigo USD 84.4M 9M Dec/2025
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 82.49M 2.82M Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025
Zoetis USD 835M 101M Dec/2025